ReposiTrak Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $23.5M+14.8% YoYTTM through 31 Mar 2026
Net Income $7.3M+22.3% YoYTTM through 31 Mar 2026
Free Cash Flow $7.5MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Gross Margin | 86.3% |
| EBITDA Margin | 36.0% |
| Operating Margin | 38.3% |
| Net Margin | 31.1% |
Returns
14.7%ROE
12.7%ROA
27.1%ROIC
Balance Sheet Health
Debt / Equity0.01x
Current Ratio4.89x
Net Debt-$26.1Mnet cash position
Cash & Equivalents$26.4M
Quality Metrics
Altman Z-Score14.21
Piotroski F-Score5 / 9
FCF Margin31.9%
Rule of 4032.5
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $22.6M
Diluted EPS$0.37TTMFY2025: $0.35
Dividend
$0.06Per share, FY20260.87%Yield
Capital Allocation
Capex Intensity0.1%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.